The global Non-Invasive Prenatal Testing (NIPT) market garnered revenue around USD XX Billion in 2019 and projected to reach USD 8 Billion in 2027, with at a compound annual growth rate of 12.9 % throughout the estimate period from 2020 to 2027.
NIPT is the testing procedure done during the pregnancy period to monitor the fetal growth and related diagnosis. Annually it is predicted that around 21 million girls aged 15 to 19 years give birth in developing regions around the globe.
Rising cases of premature pregnancy in developing and underdeveloped countries.
Availability of alternative techniques for prenatal testing.
Less accuracy of non-invasive prenatal testing compared to the invasive prenatal testing.
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Non-Invasive Prenatal Testing (NIPT) market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Non-Invasive Prenatal Testing (NIPT) market growth.
The global Non-Invasive Prenatal Testing (NIPT) market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
Illumina, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
General Electric Company [GE Healthcare] (US)
Perkinelmer, Inc. (US)
Agilent Technologies, Inc. (US)
Beijing Genomics Institute (China)
Hoffman-La Roche Ltd. (Switzerland)
Tarsa Therapeutics, Inc. (US)
PhytoHealth Corporation (Taiwan)
Laboratory Corporation of America Holdings (US)
Natera, Inc. (US)
Yourgene Health (UK)
Centogene Holding AG [CENTOGENE AG ] (Germany)
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
By Product Type
The global NIPT market based on product type is broadly segmented into devices, consumables, and others.
Devices:
Consumables:
Others:
By Techniques
The global NIPT market based on technique is segmented into biochemical screening tests and ultrasound detection.
Biochemical Screening Tests:
Ultrasound Detection:
By Application
Trisomy:
Microdeletion syndrome:
Others:
By End-User
Diagnostic Laboratories: Diagnostic laboratories are the testing setting where the NIPT test is been carried out. The labs provide various NIPT testing services as per the requirement of the patients. The diagnostic laboratories are largest segment owing to a large number of diagnostic labs/centers that provides NIPT testing products and services.
Hospitals:
Research Institutes:
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
North America
? U.S.
? Canada
Europe
? Germany
? U.K.
? Italy
? France
? Rest of EU
Asia Pacific
? China
? India
? Japan
? Southeast Asia
? Rest of APAC
Central & South America
? Brazil
? Argentina
? Rest of Central & South America
Middle East and Africa
? UAE
? Saudi Arabia
? Rest of MEA
Request Customization
Get a Sample
Get a Sample
Request Customization